A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia.
Saved in:
| Title: | A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia. |
|---|---|
| Authors: | Zeng, Yunxin1 (AUTHOR), Zhang, Xinyu1 (AUTHOR), Lin, Dongjun1 (AUTHOR), Feng, Xiaohui1 (AUTHOR), Liu, Yuye2 (AUTHOR), Fang, Zhengwen3 (AUTHOR), Zhang, Weijian2 (AUTHOR), Chen, Yu2 (AUTHOR), Zhao, Meng1,4 (AUTHOR) zhaom38@mail.sysu.edu.cn, Wu, Jun1,3 (AUTHOR) wujun29@mail.sysu.edu.cn, Jiang, Linjia2 (AUTHOR) jianglj7@mail.sysu.edu.cn |
| Source: | Journal of Hematology & Oncology. 11/8/2021, Vol. 14 Issue 1, p1-6. 6p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
